|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.
We have a diversified and growth-oriented commercial product portfolio.
Key therapeutic areas are Inflammation and Genetics & Metabolism.
Our late stage pipeline includes three phase III programs with substantial potential.
We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners.
Our sales and marketing organization covers about 20 countries in Europe and a subsidiary in the US. We are also represented through partners in in the Middle East, Australia and New Zealand.
In 2012, Sobi had total revenues of SEK 1.9 billion (€ 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com.
|
Swedish Orphan Biovitrum AB (Sobi) Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
93.75%
|
The widely used Swedish Orphan Biovitrum AB (Sobi) email format is {first}.{last} (e.g. [email protected]) with 93.75% adoption across the company.
To contact Swedish Orphan Biovitrum AB (Sobi) customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.